Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Future opportunities for passive immunity against viral diseases.

× No keyword cloud information.

11 in total

1. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.

Authors: J A Beeler; K van Wyke Coelingh
Journal: J Virol Date: 1989-07 Impact factor: 5.103

2. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes.

Authors: Jason S McLellan; Yongping Yang; Barney S Graham; Peter D Kwong
Journal: J Virol Date: 2011-05-25 Impact factor: 5.103

3. Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia.

Authors: P J Mease; H D Ochs; R J Wedgwood
Journal: N Engl J Med Date: 1981-05-21 Impact factor: 91.245

4. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.

Authors:
Journal: Pediatrics Date: 1998-09 Impact factor: 7.124

5. Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus.

Authors: Jason S McLellan; Bruno E Correia; Man Chen; Yongping Yang; Barney S Graham; William R Schief; Peter D Kwong
Journal: J Mol Biol Date: 2011-04-27 Impact factor: 5.469

6. Crystal structure of the neutralizing Llama V(HH) D7 and its mode of HIV-1 gp120 interaction.

Authors: Andreas Hinz; David Lutje Hulsik; Anna Forsman; Willie Wee-Lee Koh; Hassan Belrhali; Andrea Gorlani; Hans de Haard; Robin A Weiss; Theo Verrips; Winfried Weissenhorn
Journal: PLoS One Date: 2010-05-05 Impact factor: 3.240

7. Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma.

Authors: D A Enria; A M Briggiler; N J Fernandez; S C Levis; J I Maiztegui
Journal: Lancet Date: 1984-08-04 Impact factor: 79.321

8. Structural basis of respiratory syncytial virus neutralization by motavizumab.

Authors: Jason S McLellan; Man Chen; Albert Kim; Yongping Yang; Barney S Graham; Peter D Kwong
Journal: Nat Struct Mol Biol Date: 2010-01-24 Impact factor: 15.369

9. Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules.

Authors: Anna Hultberg; Nigel J Temperton; Valérie Rosseels; Mireille Koenders; Maria Gonzalez-Pajuelo; Bert Schepens; Lorena Itatí Ibañez; Peter Vanlandschoot; Joris Schillemans; Michael Saunders; Robin A Weiss; Xavier Saelens; José A Melero; C Theo Verrips; Steven Van Gucht; Hans J de Haard
Journal: PLoS One Date: 2011-04-01 Impact factor: 3.240

10. A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels?

Authors: Martin F Flajnik; Nick Deschacht; Serge Muyldermans
Journal: PLoS Biol Date: 2011-08-02 Impact factor: 8.029